Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial - Miller, PD; Bolognese, MA; Lewiecki, EM (Bone, 2008)
et al.